Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II randomized double-blind placebo-controlled study of topical cidofovir gel for high-grade cervical intraepithelial neoplasia
2010-023271-26Phase 2Completed
- Sponsor
- Mithra Pharmaceuticals SA
- Start
- Dec 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in cervical intraepithelial neoplasia (CIN), cervical carcinoma in situ and human papillomavirus infection comparing Cidofovir gel with Placebo gel (2 arms). Primary endpoint: Mean change of histological and cytological parameters. Started Dec 2010; status: completed.
02
Drugs
cidofovir
03
Conditions
cervical intraepithelial neoplasia (CIN)cervical carcinoma in situhuman papillomavirus infection
Beyond the preview
Go deeper on 2010-023271-26.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-023271-26.